Clinical Trial Update: The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes [Phase 1]

View source ↗

Summary

The clinical trial update notes the completion of a Phase 1 study evaluating Alpha-1 antitrypsin (AAT) for progression of Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus

Drugs mentioned

• Alpha-1 Antitrypsin (alpha-1 antitrypsin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Diabetes, Type 1 Diabetes | Phase 1 | Status: COMPLETED